Last update:
Vaccination news
Diseases, Conditions, Syndromes
AstraZeneca manufacturing error clouds vaccine study results
AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine.
5 hours ago
0
100
Vaccination
COVID vaccines: Why the safety process reassures experts
COVID-19 vaccine emergency approvals are around the corner, makers are preparing to ship millions of doses—and experts are trying to reassure the public that the record-breaking speed of development hasn't compromised safety.
6 hours ago
0
2
Flu symptoms mimic COVID-19 infection: Experts urge flu vaccination
Cases of influenza are being reported in parts of the U.S. as the COVID-19 pandemic continues. While a vaccine is not yet available for COVID-19, there is a vaccine available to prevent influenza.
6 hours ago
0
2
Less than a year to develop a COVID vaccine: Here's why you shouldn't be alarmed
I'm a clinical trials geek. I keep hearing people talk about the seven to ten years it takes to make a vaccine and how dangerous speeding this up might be. The word that keeps popping up is "rushed", and it is making the ...
12 hours ago
0
1
Tackling pandemic threats proactively
The marathon of COVID-19 vaccine development has reached the final sprint. Two leading vaccines have proven to protect 95% of vaccinated people from the disease. For the first time we can be confident that vaccines will put ...
12 hours ago
0
0
Five serendipitous medical discoveries – starting with the Oxford vaccine dose
You might assume that all great medical discoveries are the result of deliberate action on the part of scientists. But you'd be wrong. Many great discoveries are the result of accidents, mistakes and chance. Here are five ...
13 hours ago
0
0
COVID-19: four ways to respond to vaccine sceptics—and maybe even convince them
For most of the 20th century, more than 60,000 people died in the US from polio, diphtheria and small pox each year. In 2016, the American death toll from these diseases was zero. Around the globe, two to three million deaths ...
9 hours ago
0
3
Restarting global economy depends on tackling 'last mile' of vaccine journey
Restarting the global economy for billions of people will depend on successfully overcoming logistical challenges in the 'last mile' of a COVID-19 vaccine's journey to immunization stations, according to a new report.
10 hours ago
0
2
Oxford-AstraZeneca vaccine is cheaper than Pfizer's and Moderna's, and doesn't require supercold temperature
The biopharmaceutical company AstraZeneca has released data on what is now the third promising vaccine candidate against COVID-19—and it has several advantages over those of its competitors, Pfizer and Moderna.
13 hours ago
0
3
EU says first virus vaccinations possible by Christmas
Vaccinations against the coronavirus could start in the 27 European Union nations by Christmas and member countries must urgently prepare their logistical chains to cope with the rollout of hundreds of millions of doses of ...
15 hours ago
0
0
German vials in spotlight as COVID-19 vaccine nears
As expectations grow that the first COVID-19 jabs will be administered in a matter of weeks, German glassmaker Schott is quietly doing what it has been for months: churning out vials that will hold the vaccine.
18 hours ago
0
4
UPS stepping up dry ice production, freezers for vaccines
Global shipping giant UPS on Tuesday said it would start making dry ice in the United States and also distribute ultra-cold temperature freezers as it prepares to handle the logistics of shipping COVID-19 vaccines.
19 hours ago
0
2
People should know that COVID-19 vaccine might spur transient sickness: CDC experts
At least three new COVID-19 vaccine candidates are already in the pipeline, with a roll-out expected early in the new year. But on Monday, experts attending a meeting of an advisory committee to the U.S. Centers for Disease ...
Nov 24, 2020
2
5
Millions of kids are skipping vaccines this year, study finds
Millions of American children are skipping vaccines that protect against potentially deadly or disabling illnesses due to concerns about COVID-19, according to a new Blue Cross Blue Shield Association analysis of millions ...
Nov 24, 2020
0
1
Most adults over 50 say they'll get vaccinated against COVID-19, but many want to wait
Once enough people receive effective vaccines against the novel coronavirus, experts say, the end of the pandemic may be in sight. But a new poll of older adults—one of the highest-priority groups for vaccination—suggests ...
Nov 24, 2020
0
4
Keep the mask: A vaccine won't end the US crisis right away
Don't even think of putting the mask away anytime soon.
Nov 24, 2020
0
2
The next vaccine breakthrough: Health experts identify ways to help people trust a coronavirus vaccine
The pharmaceutical companies Pfizer and BioNtech announced Nov. 20, 2020, that they will seek emergency use authorization from the Food and Drug Administration for a vaccine to prevent COVID-19. On Nov. 16, Moderna announced ...
Nov 24, 2020
0
2
How pharma can build trust in COVID-19 vaccines: Transparency on trials and side effects
Promising results from large clinical trials testing three vaccines to prevent COVID-19 bring us a step closer to a widely available vaccine.
Nov 24, 2020
0
2
AstraZeneca's results signal more good vaccine news—but efficacy is only the beginning of the story
AstraZeneca has become the latest pharmaceutical company to reveal promising results in clinical trials, for its viral vector vaccine developed with the University of Oxford.
Nov 24, 2020
0
0
US to distribute 6.4 million COVID vaccine doses in first tranche
The United States plans to distribute 6.4 million doses of the Pfizer-BioNTech COVID-19 vaccine in the first week after it is cleared for emergency use, which is likely next month, officials said Tuesday.
Nov 24, 2020
0
5
